Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Internal Medicine
•
Neurology
•
Neuro-critical care
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
Related Questions
What is your threshold for initiating tocilizumab in patients with NORSE?
How do you decide on the treatment target of burst suppression pattern vs seizure cessation for patients with status epilepticus?
When do you consider vigabatrin for the treatment of status epilepticus?
How do you decide between using nuclear medicine scanning versus computed tomographic angiography (CTA) for ancillary brain death testing?
How does a patient’s BASED score after starting infantile spasms therapy guide your treatment plan?
Do you use or recommend clinical severity scores or other parameters in helping prognostication in patients with refractory status epilepticus?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
Do you start vigabatrin in patients with tuberous sclerosis prior to onset of seizures?
How do you manage a patient who has history consistent with juvenille myoclonic epilepsy (JME) but does not have the classic polyspike pattern on EEG?
In patients being evaluated for brain death, which abnormal movements are definitively known to still be consistent with brain death and which are possibly consistent with brain death but lack definitive evidence?
